房水引流物植入联合抗代谢药物治疗房角后退继发性青光眼长期疗效观察

发布时间：2018-04-22 09:11

本文选题：房水引流物植入 + 房角　；参考：《实用医学杂志》2014年16期

【摘要】：正随着当今中国工业和交通业的飞速发展,近年来眼外伤的发生率逐年上升。眼外伤并发症中较严重而又易被忽略的是继发性眼压升高和青光眼。据统计眼球挫伤后约60%~94%患者发生房角后退。部分患者由于房角后退导致小梁网撕裂,水肿而后变性萎缩丧失房水外引流功能,导致顽固性高眼压且药物无法控制。青光眼房水引流物是治疗此类外伤所致难治性青光眼的新选择。我院对房角后退继发性青光眼行房水引流物植入术,并术中联合及术后使用抗代谢药物,跟踪随访12~36个月,总体取得了较好的临床效果,现报告如下。
[Abstract]:With the rapid development of industry and transportation in China, the incidence of ocular trauma has increased year by year in recent years. Secondary IOP and glaucoma are serious and easily neglected complications of ocular trauma. According to statistics, about 60% of the patients suffered from ocular contusion. In some patients the trabecular meshwork was torn due to angle receding edema and then degenerative atrophy and lost the drainage function of aqueous humor which resulted in intractable high intraocular pressure and the drug was out of control. Glaucoma aqueous humor drainage is a new choice for the treatment of refractory glaucoma caused by trauma. Our hospital performed implantation of atrial drainage in secondary glaucoma with angle receding, combined with antimetabolic drugs during and after operation, followed up for 12 ~ 36 months, and achieved good clinical results in general. The present report is as follows.
【作者单位】：南昌大学第二附属医院眼科;
【分类号】：R779.6

【相似文献】